Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Indian Pharma Market to Hit Rs 2.38 Lakh Crore by 2025: Pharmarack Report

Farhat Nasim22 Dec 2024 12:00 PM IST

New Delhi: The Indian Pharma Market (IPM) is set to grow by 8.2% in 2025, reaching Rs 2.38 lakh crore under a realistic scenario, according to...

Cipla slapped over Rs 1 crore fine by GST Authority

Farhat Nasim21 Dec 2024 3:15 PM IST

Cipla has expressed its disagreement with the penalty, stating that it believes the order is arbitrary and unjustified.

NPPA Fixes Retail Price of 65 New Drugs, Ceiling Price of 20 Formulations, Details

Farhat Nasim21 Dec 2024 3:02 PM IST

New Delhi: Through recent notifications, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers,...

Drug alert: CDSCO flags 60 formulations as not of standard quality

NPPA Turns to Patent Office for Clarity on Drug Price Exemptions, Defers Intas, Biological E's Applications

Farhat Nasim20 Dec 2024 6:11 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought expertise from the Indian Patent Office to assist in making decisions...

Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 Days

60% of Drug Inspector Posts Vacant at CDSCO, Parliamentary Panel Calls for Immediate Staffing Review

Farhat Nasim19 Dec 2024 5:06 PM IST

New Delhi: The Parliamentary Standing Committee on Chemicals and Fertilizers has raised concerns about the staffing situation at the Central Drugs...

GST Council to Discuss Lowering Rates on Health Insurance to 5%

Farhat Nasim18 Dec 2024 5:33 PM IST

New Delhi: In a move that will significantly reducing the financial burden on policyholders, the Group of Ministers (GoM) on Health Insurance has...

Pharma Firms To Face Periodic Inspection As HC Flags Effluent Risks

Paper Publication Mandatory for Marks and Selection: NO HC Relief to Doctor Denied Assistant Professor Job

Farhat Nasim18 Dec 2024 5:13 PM IST

Patna: The Patna High Court has dismissed a writ petition filed by a doctor challenging the Bihar Public Service Commission's (BPSC) decision to...

Indian Pharma Market Grows at 9.9%, Vaccine Sales See Sharp Decline: Pharmatrac Report

Farhat Nasim16 Dec 2024 5:27 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) posted a solid 9.9% increase in value, reaching Rs 19,388 crore in November 2024. This growth was...

Only 284 Doctors in the NMR, is the National Medical Register becoming a failure?

Only 284 Doctors in NMR- Is National Medical Register becoming a failure?

Farhat Nasim16 Dec 2024 2:32 PM IST

New Delhi: The National medical Commission's (NMC) centralized database for registered medical practitioners in modern medicine, National Medical...

Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment Bevqolva

Aurobindo Pharma Slapped With Rs 11 Crore GST Demand, Plans Appeal

Farhat Nasim14 Dec 2024 6:36 PM IST

Hyderabad: Aurobindo Pharma has been hit with a Rs 11 crore GST demand by Andhra Pradesh authorities, accusing the company of overstating its Input...

Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA

Indian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA

Farhat Nasim14 Dec 2024 5:52 PM IST

Leading the market, Foracort, a respiratory drug widely used for asthma, secured the top position among brands with sales of Rs 82 crore.

Indias Medical Device Exports to US Hit by 26% Reciprocal Tariff: AiMeD Raises Concerns

Union Health Ministry Assigns Testing Labs for Surgical, Medical Examination Gloves, Amends MDR

Farhat Nasim13 Dec 2024 6:29 PM IST

New Delhi: The Union Health Ministry has amended the Medical Devices Rules, 2017, to expand testing and regulatory provisions for several critical...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok